Thursday, November 29, 2018

The U.S. Food and Drug Administration on Wednesday approved a blood cancer treatment from Japan's Astellas Pharma Inc, making it the first targeted therapy to treat patients with a certain mutation.


from Reuters: Health News https://ift.tt/2E1z13z

Related Posts:

  • LATEST HEALTH NEWSA third person has died in Brazil of suspected poisoning from a batch of craft beer contaminated with a toxic chemical used in antifreeze and other products, police in the state of Minas Gerais said on Thursday. from Reu… Read More
  • LATEST HEALTH NEWS(Reuters Health) - People who have weight-loss surgery are more likely to achieve remission of diabetes than those who try to shed excess pounds by dieting and exercising, a recent study suggests. from Reuters: Health Ne… Read More
  • LATEST HEALTH NEWSJuul Labs Inc confirmed on Tuesday it will stop selling its fruit-flavored vaping pods in Canada, a move that could help the e-cigarette maker stave off mounting scrutiny over the surging popularity of its products with teena… Read More
  • LATEST HEALTH NEWS(Reuters Health) - Common myths about low back pain could lead to more pain, ineffective care and unwarranted anxiety, researchers say. from Reuters: Health News https://ift.tt/35YVBn3 … Read More
  • LATEST HEALTH NEWS(Reuters Health) - Almost 1 in 18 women and 1 in 40 men have experienced sexual harassment in and related to the workplace, according to a U.S. study. from Reuters: Health News https://ift.tt/3669S2g … Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner